Table 4 Details of postoperative chemotherapy
Patients, n (%) | |
|---|---|
Capecitabine (1250 mg/m2 twice daily on days 1–14 of a 3-week cycle) | 3 (20.0%) |
Gemcitabine (1000 mg/m2 on days 1, 8 and 15 of a 4-week cycle) | 2 (13.3%) |
Gemcitabine + Cisplatin (1250 mg/m2 + 30 mg/m2 on days 1 and 8 of a 3-week cycle) | 9 (60.0%) |
Gemcitabine + Capecitabine (1000 mg/m2 on days 1 and 8 + 1250 mg/m2 twice daily on days 1–14 of a 3-week cycle) | 1 (6.7%) |